Dr. Adam Berger
Claim this profileRutgers Cancer Institute
Area of expertise
Melanoma
Adam Berger has run 4 trials for Melanoma. Some of their research focus areas include:
Macular Degeneration
Adam Berger has run 2 trials for Macular Degeneration.
Affiliated Hospitals
Rutgers Cancer Institute
Rutgers Cancer Institute Of New Jersey
Clinical Trials Adam Berger is currently running
Neoadjuvant Daromun + Surgery
for Melanoma
The trial aims to evaluate the efficacy of Daromun neoadjuvant treatment followed by surgery and adjuvant therapy to improve in a statistically significant manner the recurrence-free survival (RFS) of Stage IIIB/C melanoma patients with respect to the standard of care (surgery and adjuvant therapy).
Recruiting
2 awards
Phase 3
18 criteria
Surgical Excision Margins
for Melanoma
Patients with a primary invasive melanoma are recommended to undergo excision of the primary lesion with a wide margin. There is evidence that less radical margins of excision may be just as safe. This is a randomised controlled trial of 1 cm versus 2 cm margin of excision of the primary lesion for adult patients with stage II primary invasive cutaneous melanomas (AJCC 8th edition) to determine differences in disease-free survival. A reduction in margins is expected to improve patient quality of life.
Recruiting
1 award
N/A
9 criteria
More about Adam Berger
Clinical Trial Related
5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Adam Berger has experience with
- Aflibercept Injection
- KHK4951
- Panitumumab
- Talimogene Laherparepvec
- Liposomal Annamycin
- IORT With CT-Guided HDR Brachytherapy
Breakdown of trials Adam Berger has run
Melanoma
Macular Degeneration
Soft Tissue Sarcoma
Lung Metastasis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Adam Berger specialize in?
Adam Berger focuses on Melanoma and Macular Degeneration. In particular, much of their work with Melanoma has involved Stage III patients, or patients who are Stage IV.
Is Adam Berger currently recruiting for clinical trials?
Yes, Adam Berger is currently recruiting for 2 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Adam Berger has studied deeply?
Yes, Adam Berger has studied treatments such as Aflibercept Injection, KHK4951, Panitumumab.
What is the best way to schedule an appointment with Adam Berger?
Apply for one of the trials that Adam Berger is conducting.
What is the office address of Adam Berger?
The office of Adam Berger is located at: Rutgers Cancer Institute, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.